Login Register Cart 0
Generic placeholder image

Anti-Cancer Agents in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1871-5206
ISSN (Online): 1875-5992

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Editorial

Nitrogenous Heterocyclic Moiety for Drug Discovery

Author(s): Yongtao Duan and Hai-Liang Zhu

Volume 21, Issue 7, 2021

Published on: 22 January, 2021

Page: [810 - 810] Pages: 1

DOI: 10.2174/187152062107210122115431

« Previous Next »
[1]
Yongtao, D.; Hai-Liang, Z. Privileged scaffolds in drug design and activity improvement-part I. Curr. Top. Med. Chem., 2020, 20(28), 2519-2519.
[2]
Yanna, M.; Kunjal, S.; Chetan, S.; Yao, Y. An overview of privileged scaffold: Quinolines and isoquinolines in medicinal chemistry as anticancer agents. Curr. Top. Med. Chem., 2020, 20(28), 2599-2633.
[3]
Zhang, Z.; Shu, B.; Zhang, Y.; Deora, G.S.; Li, Q.-S. 2,4,5-trisubstituted thiazole: A privileged scaffold in drug design and activity improvement. Curr. Top. Med. Chem., 2020, 20(28), 2535-2577.
[4]
Man, R.J.; Jeelani, N.; Zhou, C.; Yang, Y.-S. Recent progress in the development of quinoline derivatives for the exploitation of anti-cancer agents. Anticancer Agents Med. Chem., 2021, 21(7), 825-838.
[5]
Qin, J.; Cheng, W.; Duan, Y.T.; Yang, H.; Yao, Y. Indazole as a privileged scaffold: The derivatives and their therapeutic applications. Anticancer Agents Med. Chem., 2021, 21(7), 839-860.

Rights & Permissions Print Cite
Article Metrics
10
1
© 2024 Bentham Science Publishers | Privacy Policy